{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:15:58Z","timestamp":1778580958396,"version":"3.51.4"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82204507"],"award-info":[{"award-number":["82204507"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The narrow therapeutic window and high pharmacokinetic (PK) variability of vancomycin may lead to trough concentrations outside the usual therapeutic range, requiring dose adjustments. In this study, we aimed to identify suitable pediatric vancomycin models, evaluate their predictive performance, and develop an RShiny-based multimodel informed precision-dosing (multi-MIPD) tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A systematic literature search was undertaken to identify pediatric vancomycin PK models, which were graded according to published quality-assessment criteria. Retrospective vancomycin therapeutic drug monitoring data were used to evaluate the performance of high-quality models. Consensus models (mean, median, and weighted) were constructed. In addition, a MIPD tool was developed using the free R package Shiny and validated for both initial dosing and dose adjustment. This tool was evaluated using a prospective dataset.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Nine models demonstrated excellent predictive performance in the retrospective data set (311 concentrations from 192 patients), with root-mean-square error values ranging from 1.00 to 1.97 mg\/L and median individual prediction errors from \u22120.46 to 0.42 mg\/L. The multi-MIPD tool incorporating 9 models is presented in the\n                      <jats:bold>Supplemental Digital Content 1<\/jats:bold>\n                      (see\n                      <jats:bold>Appendix<\/jats:bold>\n                      , http:\/\/links.lww.com\/TDM\/A894). The optimal model achieved a median individual prediction errors of 0.02 mg\/L, and an root-mean-square error of 0.12 mg\/L in the prospective data set (42 concentrations from 35 patients). The mean consensus model significantly improved target area under the curve attainment compared with empirical dosing, with 68.73% versus 36.53% for initial dosing and 55.56% versus 22.22% after dose adjustments.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The multi-MIPD tool provided accurate concentration predictions and, compared with empirical dosing, significantly improved vancomycin target attainment, offering a more effective and individualized dosing strategy for pediatric patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001392","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T04:01:34Z","timestamp":1759896094000},"page":"340-349","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Development and Evaluation of Multimodel Informed Precision Dosing Tool for Optimizing Vancomycin Therapy in Pediatric Patients"],"prefix":"10.1097","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6173-3414","authenticated-orcid":false,"given":"Yawen","family":"Yuan","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Cardiac Critical Care Medicine, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueling","family":"Xi","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhonghui","family":"Huang","sequence":"additional","affiliation":[{"name":"Infection, Immunity, Inflammation Section, UCL Institute of Child Health, London."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiling","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph F.","family":"Standing","sequence":"additional","affiliation":[{"name":"Infection, Immunity, Inflammation Section, UCL Institute of Child Health, London."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"R1-20260508","doi-asserted-by":"crossref","first-page":"e2020009142","DOI":"10.1542\/peds.2020-009142","article-title":"Empiric vancomycin reduction in a pediatric intensive care unit","volume":"148","author":"Lanata","year":"2021","journal-title":"Pediatrics"},{"key":"R2-20260508","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1007\/s00431-023-05103-z","article-title":"Model-informed precision dosing of antimicrobial drugs in pediatrics: experiences from a pilot scale program","volume":"182","author":"Velarde-Salcedo","year":"2023","journal-title":"Eur J Pediatr."},{"key":"R3-20260508","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s40262-021-01027-9","article-title":"Population pharmacokinetic models of vancomycin in paediatric patients: a systematic review","volume":"60","author":"Chung","year":"2021","journal-title":"Clin Pharmacokinet."},{"key":"R4-20260508","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s40262-021-01050-w","article-title":"An update on population pharmacokinetic analyses of vancomycin, part II: in pediatric patients","volume":"61","author":"Aljutayli","year":"2022","journal-title":"Clin Pharmacokinet."},{"key":"R5-20260508","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health Syst Pharm."},{"key":"R6-20260508","doi-asserted-by":"crossref","first-page":"104278","DOI":"10.1016\/j.phrs.2019.104278","article-title":"Optimisation of vancomycin exposure in neonates based on the best level of evidence","volume":"154","author":"Dao","year":"2020","journal-title":"Pharmacol Res."},{"key":"R7-20260508","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.3346\/jkms.2023.38.e101","article-title":"Evaluation of vancomycin TDM strategies: prediction and prevention of kidney injuries based on vancomycin TDM results","volume":"38","author":"Kim","year":"2023","journal-title":"J Korean Med Sci."},{"key":"R8-20260508","doi-asserted-by":"crossref","first-page":"e0013822","DOI":"10.1128\/aac.00138-22","article-title":"Relationship between vancomycin trough serum concentrations and clinical outcomes in children: a systematic review and meta-analysis","volume":"66","author":"Cao","year":"2022","journal-title":"Antimicrob Agents Chemother."},{"key":"R9-20260508","doi-asserted-by":"crossref","first-page":"e0024123","DOI":"10.1128\/aac.00241-23","article-title":"Plasma and cerebrospinal fluid population pharmacokinetics of vancomycin in patients with external ventricular drain","volume":"67","author":"Chen","year":"2023","journal-title":"Antimicrob Agents Chemother."},{"key":"R10-20260508","doi-asserted-by":"crossref","first-page":"e0159123","DOI":"10.1128\/aac.01591-23","article-title":"Prospective validation of a model-informed precision dosing tool for vancomycin treatment in neonates","volume":"68","author":"Kalamees","year":"2024","journal-title":"Antimicrob Agents Chemother."},{"key":"R11-20260508","doi-asserted-by":"crossref","first-page":"e882","DOI":"10.1093\/infdis\/jiaf059","article-title":"Prediction of vancomycin area under the curve with trough concentrations only: performance evaluation of pediatric population pharmacokinetic models","volume":"231","author":"Schouwenburg","year":"2025","journal-title":"J Infect Dis."},{"key":"R12-20260508","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1128\/AAC.00577-16","article-title":"Development and evaluation of a gentamicin pharmacokinetic model that facilitates opportunistic gentamicin therapeutic drug monitoring in neonates and infants","volume":"60","author":"Germovsek","year":"2016","journal-title":"Antimicrob Agents Chemother."},{"key":"R13-20260508","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/FTD.0000000000001214","article-title":"Developing parametric and nonparametric models for model-informed precision dosing: a quality improvement effort in vancomycin for patients with obesity","volume":"46","author":"Hughes","year":"2024","journal-title":"Ther Drug Monit."},{"key":"R14-20260508","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/FTD.0000000000001323","article-title":"Model-informed precision dosing of vancomycin in Vietnamese children: innovative midpoint concentration monitoring using 2 Bayesian programs","volume":"47","author":"Hai","year":"2025","journal-title":"Ther Drug Monit"},{"key":"R15-20260508","doi-asserted-by":"crossref","first-page":"88","DOI":"10.12688\/wellcomeopenres.16718.1","article-title":"An automated approach to identify scientific publications reporting pharmacokinetic parameters","volume":"6","author":"Gonzalez Hernandez","year":"2021","journal-title":"Wellcome Open Res."},{"key":"R16-20260508","doi-asserted-by":"crossref","first-page":"23485","DOI":"10.1038\/s41598-024-73338-3","article-title":"Named entity recognition of pharmacokinetic parameters in the scientific literature","volume":"14","author":"Gonzalez Hernandez","year":"2024","journal-title":"Sci Rep."},{"key":"R17-20260508","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/QCO.0b013e328353105c","article-title":"Antibiotic dosing in children in Europe: can we grade the evidence from pharmacokinetic\/pharmacodynamic studies\u2014and when is enough data enough?","volume":"25","author":"Barker","year":"2012","journal-title":"Curr Opin Infect Dis."},{"key":"R18-20260508","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1080\/17512433.2019.1695600","article-title":"GAPPS (grading and assessment of pharmacokinetic-pharmacodynamic studies) a critical appraisal system for antimicrobial PKPD Studies\u2014development and application in pediatric antibiotic studies","volume":"12","author":"Gastine","year":"2019","journal-title":"Expert Rev Clin Pharmacol."},{"key":"R19-20260508","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s11096-024-01745-7","article-title":"Optimizing vancomycin dosing in pediatrics: a machine learning approach to predict trough concentrations in children under four years of age","volume":"46","author":"Yin","year":"2024","journal-title":"Int J Clin Pharm."},{"key":"R20-20260508","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1128\/AAC.02564-13","article-title":"Population pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease","volume":"58","author":"Zhao","year":"2014","journal-title":"Antimicrob Agents Chemother."},{"key":"R21-20260508","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2125.2005.02432.x","article-title":"Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenation","volume":"60","author":"Mulla","year":"2005","journal-title":"Br J Clin Pharmacol."},{"key":"R22-20260508","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/jac\/dky525","article-title":"Development and external evaluation of a population pharmacokinetic model for continuous and intermittent administration of vancomycin in neonates and infants using prospectively collected data","volume":"74","author":"Germovsek","year":"2019","journal-title":"J Antimicrob Chemother."},{"key":"R23-20260508","doi-asserted-by":"crossref","first-page":"F221","DOI":"10.1136\/fn.81.3.F221","article-title":"Pharmacokinetics and dose requirements of vancomycin in neonates","volume":"81","author":"Grimsley","year":"1999","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"R24-20260508","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s40262-018-0727-5","article-title":"Vancomycin pharmacokinetics throughout life: results from a pooled population analysis and evaluation of current dosing recommendations","volume":"58","author":"Colin","year":"2019","journal-title":"Clin Pharmacokinet."},{"key":"R25-20260508","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1093\/jac\/dkz158","article-title":"Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants","volume":"74","author":"Jacqz-Aigrain","year":"2019","journal-title":"J Antimicrob Chemother."},{"key":"R26-20260508","doi-asserted-by":"crossref","first-page":"648668","DOI":"10.3389\/fphar.2021.648668","article-title":"Modeling approach to optimizing dose regimen of vancomycin for Chinese pediatric patients with Gram-positive bacterial infections","volume":"12","author":"Shen","year":"2021","journal-title":"Front Pharmacol."},{"key":"R27-20260508","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s13318-021-00730-z","article-title":"Pharmacokinetics of vancomycin in critically ill children: a systematic review","volume":"47","author":"Akunne","year":"2022","journal-title":"Eur J Drug Metab Pharmacokinet."},{"key":"R28-20260508","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s13318-019-00568-6","article-title":"Clinical pharmacokinetics of vancomycin in critically ill children","volume":"44","author":"Sridharan","year":"2019","journal-title":"Eur J Drug Metab Pharmacokinet."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:43:58Z","timestamp":1778579038000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001392","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"2025-06-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}